Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. First observed

TDQS

A4.8/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already signal readOnly/idempotent; the description adds a rich account of fan-out sources, soft-fail for patents, expected empty results for small-molecule-only companies, sources_used/sources_failed semantics, and name-to-CIK resolution. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Long but front-loaded and organized; trigger phrases and primary recommendation come first, followed by a structured source/return breakdown. Some sentences repeat schema content (notably the type interchangeability clause), so it is thorough rather than maximally lean.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a complex tool with no output schema, the description is exceptionally complete: it names every return section, explains what absence means, and covers failure and resolution cases. An agent has enough to call it correctly and interpret results.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema already documents both parameters at 100% coverage, but the description adds concrete examples, the zero-padded CIK requirement, name resolution via SEC EDGAR, and private-company resolved:false behavior. Slight redundancy with schema but meaningful added value.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description names the exact operation ('full cross-source profile of a US public company'), supplies natural-language trigger phrases, and contrasts with chaining single-source lookups. It distinguishes the tool from generic research siblings by emphasizing 'ONE parallel call' and an entity-centric scope.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly instructs ALWAYS PREFER over chaining single-pack lookups when the user wants a holistic view, and gives trigger examples. Also explains behavior for private companies and interchangeable type/value shapes, leaving little ambiguity about when to invoke.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.5/5.0
Disambiguation2/5

The tool set includes both OpenReview-specific tools (e.g., get_paper, list_submissions) and a large number of unrelated tools for Pipeworx, Polymarket, and SEC filings. While individual descriptions are clear, the mix of domains creates confusion about which tools to use for a given task, leading to potential misselection.

Naming Consistency2/5

Tool names follow inconsistent patterns: some use underscore_case (ai_visibility_check, generate_llms_txt), some are verb_noun (get_paper, list_venues), and others use descriptive phrases (ask_pipeworx_grounded, polymarket_arbitrage). The lack of a unified naming scheme makes the tool set feel disjointed.

Tool Count2/5

With 37 tools, the count is too high for a server supposedly focused on OpenReview. Only about 6 tools are directly related to OpenReview; the rest are for unrelated domains like prediction markets, data retrieval, and memory management. The scope is unclear and overloaded.

Completeness2/5

For the OpenReview domain, the tool set covers basic retrieval (get_paper, search_notes, list_submissions) but lacks operations like creating or updating notes, which are common in a review platform. The inclusion of many non-OpenReview tools does not compensate for these gaps, leaving the surface incomplete for its stated purpose.